ANTICANCER, INC.

Basic Information

7917 OSTROW ST
SAN DIEGO, CA, 92111-3604

Company Profile

n/a

Additional Details

Field Value
DUNS: 173844010
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Pancreatic-Cancer Imageable Patient-Derived Orthotopic Xenografts (iPDOX)

    Amount: $224,700.00

    DESCRIPTION (provided by applicant): Individualized cancer treatment is an important goal, in particular, for pancreatic cancer, which is the most lethal human cancer. Novel transformative therapeutic ...

    SBIR Phase I 2014 Department of Health and Human Services
  2. Hair follicle nestin-expressing stem cells on a scaffold for nerve repair

    Amount: $224,700.00

    DESCRIPTION (provided by applicant): Nestin-expressing stem cells of the hair follicle, discovered by our laboratory (Proc Natl Acad Sci USA 2003; 100:9658-61[1]), have been shown by our laboratory to ...

    SBIR Phase I 2014 Department of Health and Human Services
  3. Targeted tumoricidal bacteria

    Amount: $761,149.00

    DESCRIPTION (provided by applicant): We have developed an effective bacterial cancer therapy strategy by targeting viable tumor tissue by using Salmonella typhimurium auxotrophs that we have generated ...

    SBIR Phase II 2010 Department of Health and Human Services
  4. Adenoviral GFP targeting of metastatic human tumors using multiple delivery route

    Amount: $149,575.00

    DESCRIPTION (provided by applicant): We are developing a new approach to image tumors by selectively targeting the tumors in vivo with a telomerase-specific replication-competent adenovirus expressing ...

    SBIR Phase I 2008 Department of Health and Human Services
  5. Targeted tumoricidal bacteria

    Amount: $149,799.00

    DESCRIPTION (provided by applicant): The goal of this application is to develop imageable tumor-targeting bacteria that can cure tumors without progressive infection of the host. Previous experiments ...

    SBIR Phase I 2007 Department of Health and Human Services
  6. Orthotopic models of tumor angiogenesis and blood flow

    Amount: $749,696.00

    DESCRIPTION (provided by applicant): There is a need for clinically-relevant imageable animal models of tumor blood flow, intravascular cancer-cell trafficking and extravasation, critical targets for ...

    SBIR Phase II 2006 Department of Health and Human Services
  7. Dual-color tumor-host imaging models

    Amount: $751,568.00

    DESCRIPTION (provided by applicant): This Phase II application will further develop dual-color imageable tumor-host-interaction nude mouse models, developed in the Phase I application, to be used in P ...

    SBIR Phase II 2006 Department of Health and Human Services
  8. Therapeutic hair follicle-derived neurospheres

    Amount: $749,000.00

    DESCRIPTION (provided by applicant): The facile availability of pluripotent adult stem cells would have many important therapeutic applications. Our recent results suggest that the hair follicle is a ...

    SBIR Phase II 2006 Department of Health and Human Services
  9. Imageable tumor-targeting bacteria

    Amount: $149,800.00

    DESCRIPTION (provided by applicant): The goal of this application is to develop imageable tumor-targeting bacteria that can cure tumors without progressive infection of the host. Previous experiments ...

    SBIR Phase I 2006 Department of Health and Human Services
  10. Enzyme therapy for hyperhomocysteinemia

    Amount: $149,800.00

    DESCRIPTION (provided by applicant): Numerous studies have demonstrated that homocysteine (HCY) is a major risk factor in heart disease and stroke. Recent studies have shown that lowering HCY levels w ...

    SBIR Phase I 2005 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government